Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;24(6):1800004.
doi: 10.2807/1560-7917.ES.2019.24.6.1800004.

Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel

Affiliations

Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel

Chen Stein-Zamir et al. Euro Surveill. 2019 Feb.

Abstract

BackgroundChildhood vaccination schedules recommend vaccine doses at predefined ages.AimWe evaluated vaccination completeness and timeliness in Jerusalem, a district with recurrent vaccine-preventable disease outbreaks.MethodsVaccination coverage was monitored by the up-to-date method (vaccination completeness at age 2 years). Timeliness of vaccination was assessed in children (n = 3,098, born in 2009, followed to age 48 months, re-evaluated at age 7 years) by the age-appropriate method (vaccine dose timeliness according to recommended schedule). Vaccines included: hepatitis B (HBV: birth, 1 month and 6 months); diphtheria, tetanus, acellular pertussis, polio, Haemophilus influenzae b (DTaP-IPV-Hib: 2, 4, 6 and 12 months); pneumococcal conjugate (PCV: 2, 4 and 12 months); measles-mumps-rubella/measles-mumps-rubella-varicella (MMR/MMRV: 12 months) and hepatitis A (HAV: 18 and 24 months).ResultsOverall vaccination coverage (2014 cohort evaluated at age 2 years) was 95% and 86% for MMR/MMRV and DTaP-IPV-Hib4, respectively. Most children (94%, 91%, 79%, 95%, 92% and 82%) were up-to-date for HBV3, DTaP-IPV-Hib4, PCV3, MMR/MMRV1, HAV1 and HAV2 vaccines at 48 months, but only 32%, 28%, 38%, 58%, 49% and 20% were vaccinated timely (age-appropriate). At age 7 years, the median increase in vaccination coverage was 2.4%. Vaccination delay was associated with: high birth order, ethnicity (higher among Jews vs Arabs), birth in winter, delayed acceptance of first dose of DTaP-IPV-Hib and multiple-dose vaccines (vs MMR/MMRV). Jewish ultra-Orthodox communities had low vaccination coverage.ConclusionsConsiderable vaccination delay should be addressed within the vaccine hesitancy spectrum. Delays may induce susceptibility to vaccine-preventable disease outbreaks; tailored programmes to improve timeliness are required.

Keywords: childhood vaccination; children; infants; measles; routine vaccinations; toddlers; vaccination completeness; vaccination coverage; vaccination schedules; vaccination timeliness; vaccines and immunisation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Incidence of selected notifiable vaccine-preventable diseasesa and reported overall mean coverage of selected routine childhood vaccinationsb, Jerusalem district, Israel, 2000–2016
Figure 2
Figure 2
The cumulative proportion of vaccine uptake by child’s age in months using the inverse Kaplan-Meier curves for selected vaccine dosesa, in children born in 2009 and followed up to 7 years of age, Jerusalem district, Israel, 2016 (n = 3,098)
Figure 3
Figure 3
Distribution of vaccination coverage by defined categories (status at the age of 48 months) for selected vaccine doses, in children born in 2009, Jerusalem district, Israel, 2016 (n = 3,098)
Figure 4
Figure 4
The cumulative proportion of vaccination uptake by age for (A) DTaP-IPV-Hib4 and (B) MMR/MMRV1a, in children born in 2009 and followed up to 7 years of age, by main population groups, Jerusalem district, Israel 2016 (n = 3,098)

References

    1. World Health Organization (WHO). Immunization coverage. Geneva: WHO; 2018. Available from: http://www.who.int/mediacentre/factsheets/fs378/en/
    1. Subaiya S, Dumolard L, Lydon P, Gacic-Dobo M, Eggers R, Conklin L, Centers for Disease Control and Prevention (CDC) Global routine vaccination coverage, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(44):1252-5. 10.15585/mmwr.mm6444a5 - DOI - PubMed
    1. World Health Organization (WHO). Global Vaccine Action Plan. Geneva: WHO; 2015. Available from: http://www.who.int/immunization/global_vaccine_action_plan/gvap_secretar...
    1. Rubin L, Belmaker I, Somekh E, Urkin J, Rudolf M, Honovich M, et al. Maternal and child health in Israel: building lives. Lancet. 2017;389(10088):2514-30. 10.1016/S0140-6736(17)30929-7 - DOI - PubMed
    1. Tasher D, Rubin L, Grossman Z, Grotto I, Dahan D, Berlowitz Y, et al. Child Health Care in Israel. J Pediatr. 2016;177:S107-15. 10.1016/j.jpeds.2016.04.047 - DOI - PubMed

MeSH terms

Substances